Key Takeaway
The CJC-1295 Ipamorelin stack is one of the most widely prescribed peptide combinations for supporting natural growth hormone production. If you have been researching peptide therapy for anti-aging, recovery, body composition, or sleep quality, you have likely come across this pairing.
The CJC-1295 Ipamorelin stack is one of the most widely prescribed peptide combinations for supporting natural growth hormone production. If you have been researching peptide therapy for anti-aging, recovery, body composition, or sleep quality, you have likely come across this pairing. In this article, we explain how each peptide works, why they are often combined, what the research shows, and what you should know before starting.
Key Takeaways: - Learn how cjc-1295 and ipamorelin work together - Typical Dosing and Protocol Structure - Understand what the research shows - Side Effects and Safety Considerations
How CJC-1295 and Ipamorelin Work Together
CJC-1295 and Ipamorelin both stimulate growth hormone release, but they do it through different mechanisms. This is what makes the combination potentially more effective than either peptide alone.
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog. It works by binding to GHRH receptors in the pituitary gland, signaling it to produce and release growth hormone. The modified version (CJC-1295 with DAC) has an extended half-life of about 6-8 days, while the version without DAC (also called Mod GRF 1-29) has a much shorter half-life.
Ipamorelin is a growth hormone secretagogue. It works by mimicking the hunger hormone ghrelin and binding to ghrelin receptors in the pituitary. This triggers a separate signaling pathway for growth hormone release. Unlike some other secretagogues, Ipamorelin is selective. It stimulates growth hormone without significantly raising cortisol or prolactin levels.
When you combine them, you activate two different pathways at the same time. Think of it like pressing the gas pedal (CJC-1295 amplifies the signal) and releasing the brake (Ipamorelin triggers the release). The result may be a stronger, more consistent growth hormone pulse than either peptide produces alone.
"What makes tirzepatide particularly interesting is the dual GIP/GLP-1 mechanism. We're seeing that GIP receptor activation appears to amplify the metabolic effects in ways we didn't fully anticipate from the preclinical data.") Dr. Ania Jastreboff, MD, PhD, Yale School of Medicine, lead author of SURMOUNT-1
This dual-action approach is why providers frequently prescribe them together rather than individually. To understand more about peptide therapy options, for another commonly prescribed peptide.
Typical Dosing and Protocol Structure
A licensed provider will determine the right dosing for your individual needs. The following is a general overview of how this stack is commonly prescribed.
Most providers prescribe CJC-1295 (without DAC) at 100-300 mcg per injection and Ipamorelin at 100-300 mcg per injection. These are typically administered together via subcutaneous injection.
The timing of injections matters. Growth hormone is naturally released in pulses, with the largest pulse occurring during deep sleep. Many providers recommend dosing before bed to work with your body's natural rhythm. Some protocols call for two or three doses per day, such as upon waking, post-workout, and before bed.
A typical cycle runs 8-12 weeks, followed by a 4-week off period. This cycling approach helps prevent receptor desensitization and allows your pituitary to maintain its natural function. Some providers use a 5-days-on, 2-days-off weekly schedule within the cycle.
It is best to inject on an empty stomach or at least 2 hours after eating. Food, especially carbohydrates, can blunt the growth hormone response by raising insulin levels.
Both peptides require reconstitution with bacteriostatic water before injection. to get accurate measurements every time.
Free Download: Wolverine Stack Protocol Card Get a printable reference card with peptide stacking protocols, including CJC-1295/Ipamorelin dosing schedules and cycling guidelines. Get yours free (we'll email it to you instantly. [Download Now]
What the Research Shows
Research on CJC-1295 and Ipamorelin individually has shown promising results, though large-scale combined studies in humans remain limited.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →A study on CJC-1295 with DAC found that a single dose increased mean growth hormone levels by 2-10 times for up to 6 days. IGF-1 levels (a downstream marker of growth hormone activity) also increased by 1.5-3 times. Participants tolerated the peptide well, with injection site reactions being the most common side effect.
Ipamorelin studies have demonstrated dose-dependent growth hormone release with minimal impact on other hormones. One study showed that Ipamorelin produced growth hormone release similar to GHRP-6 but without the appetite-stimulating and cortisol-raising effects that GHRP-6 is known for.
The potential benefits that people report from this stack include improved sleep quality, faster recovery from exercise, reduced body fat with maintained muscle mass, improved skin elasticity, and better overall energy levels. However, individual results vary significantly, and these outcomes are not guaranteed.
It is important to note that growth hormone therapy is a complex area of medicine. Too much growth hormone can cause side effects including joint pain, water retention, and carpal tunnel-like symptoms. This is why provider supervision and proper dosing are critical.
For more on how peptide stacks compare, read .
Side Effects and Safety Considerations
The CJC-1295 and Ipamorelin stack is generally well-tolerated when prescribed and monitored by a licensed provider. However, there are side effects to be aware of.
Common side effects include injection site redness or irritation, mild headaches, flushing, and temporary water retention. These typically resolve on their own within the first few weeks of treatment. Some people experience vivid dreams or increased sleepiness when dosing before bed, which is actually related to the improved deep sleep many users report.
Less common side effects can include numbness or tingling in the hands, joint stiffness, or lightheadedness. If you experience these, contact your provider. They may need to adjust your dosage.
Growth hormone-stimulating peptides are not appropriate for everyone. You should not use this stack if you have active cancer, as growth hormone may promote cell proliferation. People with a history of pituitary disorders, uncontrolled diabetes, or active retinopathy should also avoid growth hormone therapies without careful medical evaluation.
Your provider will likely order blood work before starting, including IGF-1 levels, fasting glucose, and a basic metabolic panel. Mid-cycle labs help ensure your levels are in a healthy range. This monitoring is an important part of safe peptide therapy.
Always source your peptides from a licensed US-based 503A compounding pharmacy. FormBlends works exclusively with licensed pharmacies to ensure purity and proper preparation.
Frequently Asked Questions
How quickly will I notice results from the CJC-1295 and Ipamorelin stack?
Many people report improved sleep quality within the first 1-2 weeks. Changes in body composition, recovery, and energy levels typically take 4-8 weeks to become noticeable. Full benefits may take a complete 8-12 week cycle to assess.
Can I use this stack with other peptides?
Some providers do combine CJC-1295/Ipamorelin with healing peptides like BPC-157. However, adding peptides increases complexity and potential for interactions. Never add peptides to your protocol without your provider's approval.
Should I take CJC-1295 and Ipamorelin at the same time?
Yes, they are typically injected together at the same time. Many providers prescribe them in the same syringe for convenience. Dosing before bed is the most common recommendation.
Will this stack show up on a drug test?
Growth hormone secretagogues are banned by most athletic organizations including WADA. If you are a competitive athlete subject to drug testing, discuss this with your provider before starting.
Do I need to fast before injecting?
It is recommended to inject on an empty stomach or at least 2 hours after eating. Elevated insulin from food can reduce the growth hormone response to these peptides.
Ready to Take the Next Step?
Your treatment plan is personal) and you deserve a plan that fits. FormBlends connects you with licensed providers who can evaluate your needs and create a personalized protocol.
Sources & References
- Sikiric P, Hahm KB, Blagaic AB, et al. Stable Gastric Pentadecapeptide BPC 157, Robert's Cytoprotection, Adaptive Cytoprotection, and Therapeutic Effects. Curr Pharm Des. 2018;24(18):1990-2001. Doi:10.2174/1381612824666180515125918
- Chang CH, Tsai WC, Lin MS, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780. Doi:10.1152/japplphysiol.00945.2010
- Seiwerth S, Brcic L, Vuletic LB, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-1125. Doi:10.2174/13816128113199990421
- Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-472. Doi:10.1038/nature03000
- Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. Doi:10.1046/j.1523-1747.1999.00708.x
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797. Doi:10.1210/jc.2006-1702
The information in this article is intended for educational use only and should not be considered medical advice. Consult a qualified healthcare provider before making any changes to your medication or supplement regimen. FormBlends helps with connections with licensed providers for personalized medical guidance.
Last updated: 2026-03-24